Mid Year Newsletter

For the first half of this year it has been all systems go with the doctors, staff and directors working hard to keep up with the big changes occurring in this cutting edge industry.

0108STEM CELLS .jpg

Clinical Studies updates.....

We are currently doing the latest data collection of our arthroscopic knee surgery in combination with stem cells study, which has been running now for about 2.5 years.  Associate professor Dr Julien Freitag is currently re-assessing our trial participants this month, with some being 2 years post therapy. The preliminary data looks encouraging and we will keep you up to date with how this exciting publication is progressing. 

Dr Freitag and the team are also reviewing the results from the Randomised Control Trial we commenced some three years ago with patients with osteoarthritis of the knee. The preliminary results demonstrate clear statistical improvement in pain and functional mobility and activity, with some of the trial participants showing evidence of cartilage regrowth. We hope to submit this study for publication in the coming months.


Dr Dan Bates is back!!

We are so excited to welcome back one of the founding members of our team. Dan has been on sabbatical from MSCC while he has been working on his specialty of dealing with complex back pain and sports related injuries.  Dan will be consulting with us on a Monday morning, every second week and is available for appointments. To learn more about Dan’s philosophy please click here

Melbourne stem cell centre has been working closely with the therapeutic goods administration around the proposed new regulation of the stem cell industry. You may notice a few changes around the clinic as we strive to continue to be at the forefront of stem cell research in Australia. To view our submission to the TGA please click here

We are about to commence a phase one and two trial using allogeneic (donor provided) stem cells, with patient recruitment near to completion. We are excited about this significant trial into the safety and efficacy of selected donors cells (allogeneic cells). We hope to replicate the results that we have demonstrated with autologous cells. We expect this trial to take around 12 months to complete.


Dr David Vivian

We are very lucky to welcome a new doctor to the team! Dr David Vivian will be working at Melbourne Stem Cell Centre focusing on the conservative management of osteoarthritis with a special interest in backs, necks and knees. David will commence work with us over the coming months with 1 session a fortnight, and increasing if required. He will work closely with our team of clinicians and proceduralists to assure the best outcome for patients.

We said goodbye to our nurse/receptionist Phoebe in March. We wish her all the best of luck with her new nursing job after recently completing her enrolled nurse qualification.


Patient Expectations

Our senior nurse, Lucinda is soon to submit her Bachelor of Nursing Honours thesis for assessment.  Her study on patient expectations and experience of stem cell treatment consisting of a pre-treatment group and a post treatment group, is a landmark study and the first of its kind in the published literature. We are very proud of her achievement.

We will be welcoming Renee back from maternity leave in July, she will be working two days a week focusing on administration, staff development and clinical roles. She is really looking forward to returning and seeing how much the clinic has grown in the time she has been away.